glp-1 and gallbladder issues FDA Data Link Diabetes Drug Class to Disease Gallbladder Risks with GLP-1 Medications

Levels decline with age and drop further in chronic disease, including Parkinson's disease, liver disease, heart disease, and alcohol use disorder

We found that among patients with diabetes aged 66 and older, the incidence of nAMD was approximately 1 in 1,000 in those who had never used GLP-1 receptor agonists, compared to about 2 in 1,000 among those who had been exposed to these medications for at least six months, Muni said

Dexcom G7 is an important partner to GLP-1s Image shown does not include required overpatch

In the phase II dose-ranging study discussed previously, patients receiving larger doses of semaglutide (i.e., 40 mg vs